• Collegium Pharmaceutical director John Gordon Freund sold 20 common shares on May 18 at USD 34.05.
• Direct holdings stood at 83,952 shares following the transaction.
• He also reported indirect ownership of 23,129 shares through John Freund Family Partnership IV, L.P., with another 8,625 shares held through Skyline Venture Management V, LLC.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Collegium Pharmaceutical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001296771-26-000004), on May 20, 2026, and is solely responsible for the information contained therein.